You can buy or sell Heska and other stocks, options, ETFs, and crypto commission-free!
Heska Corp. engages in the provision of veterinary and animal health diagnostic, and specialty products. It operates through two segments: Core Companion Animal Health and Other Vaccines & Pharmaceuticals. Read More The Core Companion Animal Health segment includes point of care diagnostic laboratory instruments and supplies, imaging instruments, software, and services as well as single use diagnostic and other tests, pharmaceuticals, and vaccines. The Other Vaccines & Pharmaceuticals segment focuses on private label vaccine and pharmaceutical production, primarily for cattle, but also for equine, porcine, avian, feline, and canine. Heska was founded by Robert B. Grieve and Lynnor B. Stevenson in 1988 and is headquartered in Loveland, CO.
52 Week High
52 Week Low
Simply Wall St14h
Read This Before Buying Heska Corporation (NASDAQ:HSKA) Shares
We’ve lost count of how many times insiders have accumulated shares in a company that goes on to improve markedly. The flip side of that is that there are more than a few examples of insiders dumping stock prior to a period of weak performance. So we’ll take a look at whether insiders have been buying or selling shares in Heska Corporation (NASDAQ:HSKA). Do Insider Transactions Matter? It’s quite normal to see company insiders, such as board members, trading in company stock, from time to time. However, s...
Heska Corporation Announces New Board Member Mark Furlong
LOVELAND, Colo., March 8, 2019 /PRNewswire/ -- Heska Corporation (NASDAQ:HSKA, ", Heska", or the ", Company", )), a provider of advanced veterinary diagnostic and specialty products, announced that Mark Furlong has joined the Company's Board of Directors (the "Board"). Mr. Furlong is the former President and Chief Executive Officer of BMO Harris Bank, N.A., a role he held from the acquisition of Marshall & Ilsley Corporation by BMO Financial Group in 2011 until his retirement in June 2015. He joined Marsha...
Guru FocusMar 7
Heska Corp (HSKA) Files 10-K for the Fiscal Year Ended on December 31, 2018
Heska Corp (NASDAQ:HSKA) files its latest 10-K with SEC for the fiscal year ended on December 31, 2018. Heska Corp is engaged in developing, manufacturing, marketing, selling and supporting veterinary products.
Expected May 3, Pre-Market